Articles and Publications

• Some Medications and Driving Don't Mix
• What You Should Know about Prescription Drug Advertisements 
• Safe Disposal of Medication 
• Oxycodone: Protect Your Teens (pdf, 198KB)
• Prescription Drug Abuse Among Teens (pdf, 193KB)
• Buying Prescription Medication On-line (pdf, 135KB)
• Medication Safety: Who's at Risk & What You Can Do (pdf, 164KB)
• Safe Storage and Disposal of Prescription Medication (pdf, 278KB)
• Opioids: What You Need to Know (pdf, 222KB)

• Protecting Yourself from Prescription Errors (pdf, 174KB)
• News report on prescription errors

• How You Can Help Reduce Prescription Drug Abuse Overview for Professionals
• Controlled Substance Charges and Schedules
• Connecticut Drug Laws and Regulations
  • FDA Information Regarding Ranbaxy Laboratories Ltd.
    • News Release: Warning Letters Issued to Ranbaxy Laboratories Ltd., and an Import Alert for Drugs from Two Ranbaxy Plants in India
    • A List of Drugs Manufactured at the Dewas and Paonta Sahib Facilities of Ranbaxy Laboratories, Ltd.
    • Q & A about the Ranbaxy Laboratories Warning

• Connecticut Laws Impacting Prescribing and Practice
• Pharmacy and Practitioner Advisory  Drug Enforcement Agency advisory on the distribution of methadone tablets. As of January 1, 2008, manufacturers of methadone hydrochloride tablets 40 mg (dispersible) voluntarily agreed to restrict distribution of this formulation to only those facilities authorized for detoxification and maintenance treatment of opioid addiction, and hospitals. More...
• Talking to Patients About Cannabis Use

Presentations

• 2023 Drug Control Legislative Updates CE Presentation